|
TBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.541590E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.499600E-02 |
| Normal-vs-Stage2 |
4.485600E-01 |
| Normal-vs-Stage3 |
6.560800E-01 |
| Normal-vs-Stage4 |
7.290000E-01 |
| Stage1-vs-Stage2 |
4.557200E-01 |
| Stage1-vs-Stage3 |
2.458200E-01 |
| Stage1-vs-Stage4 |
4.108400E-01 |
| Stage2-vs-Stage3 |
8.204800E-01 |
| Stage2-vs-Stage4 |
8.136600E-01 |
| Stage3-vs-Stage4 |
9.707000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.215200E-01 |
| Normal-vs-AfricanAmerican |
4.527600E-01 |
| Normal-vs-Asian |
1.038210E-01 |
| Caucasian-vs-AfricanAmerican |
3.455000E-01 |
| Caucasian-vs-Asian |
5.385200E-01 |
| AfricanAmerican-vs-Asian |
3.503600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.933900E-02 |
| Normal-vs-Female |
4.899200E-01 |
| Male-vs-Female |
2.185200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.631360E-01 |
| Normal-vs-Extreme_Weight |
2.074500E-02 |
| Normal-vs-Obese |
4.407800E-01 |
| Normal-vs-Extreme_Obese |
1.637830E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.847400E-01 |
| Normal_Weight-vs-Obese |
4.678000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.790800E-01 |
| Extreme_Weight-vs-Obese |
6.313800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.409000E-01 |
| Obese-vs-Extreme_Obese |
4.611600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.568800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.203600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.564400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.104600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.146200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.016400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.862200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.764260E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.183800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.728300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.047800E-01 |
| Normal-VS-Type2 PRCC |
8.697400E-03 |
| Normal-VS-KIRP CIMP |
6.854800E-01 |
| Normal-VS-Unclassified PRCC |
9.253600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.200200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.249600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.066160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.524200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.730200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.993230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.416600E-04 |
| Normal-vs-N1 |
8.459600E-01 |
| Normal-vs-N2 |
9.500700E-03 |
| N0-vs-N1 |
3.141400E-03 |
| N0-vs-N2 |
2.473600E-01 |
| N1-vs-N2 |
3.557700E-02 |
|
|
